Latest News about BCRX

Recent news which mentions BCRX

< Previous 1 2 3 4 5 6 Next >

Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

August 04, 2022

3 Fast-Growing Stocks to Buy Now

July 31, 2022

2 Biotech Stocks You'll Regret Not Buying on the Dip

July 18, 2022

Why BioCryst Pharmaceuticals Topped the Market Today

June 08, 2022

BioCryst Gets FDA Fast Track Designation For Bone Formation Disorder Candidate

June 08, 2022

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

June 08, 2022

7 Cheap Biotech Stocks to Buy Now

May 19, 2022

9 Health Care Stocks With Whale Alerts In Today's Session

May 18, 2022

Why BioCryst Stock Lost Nearly 4% of Its Value Today

May 05, 2022

BioCryst's Voluntary Pause Of Rare Blood Disorder Trial Turns Into FDA Clinical Hold

May 05, 2022

BioCryst Pharmaceuticals (BCRX) Q1 2022 Earnings Call Transcript

May 05, 2022

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

May 05, 2022

Recap: BioCryst Pharmaceuticals Q1 Earnings

May 05, 2022

10 Health Care Stocks With Whale Alerts In Today's Session

May 02, 2022

Why BioCryst Stock Shot Nearly 5% Higher Today

April 27, 2022

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

April 27, 2022

7 Top-Rated Biotech Stocks to Buy for Q2

April 21, 2022

After Falling 21% in a Month, Is There Any Hope for BioCryst Pharmaceuticals?

April 19, 2022

Why BioCryst Pharmaceuticals Stock Sank Today

April 18, 2022

What 4 Analyst Ratings Have To Say About BioCryst Pharmaceuticals

April 18, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

April 18, 2022

Why BioChryst Pharmaceuticals' Stock Jumped 14.7% This Week

April 14, 2022

28 Biggest Movers From Yesterday

April 14, 2022

10 Health Care Stocks Whale Activity In Today's Session

April 11, 2022

Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16

April 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022

April 11, 2022

Why BioCryst Pharmaceuticals Stock Is Falling

April 11, 2022

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%

April 08, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

April 08, 2022

28 Stocks Moving In Friday's Mid-Day Session

April 08, 2022

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.